Todoc To Launch Low-Cost Artificial Cochlear Implant System Sullivan At Ces 2022

Todoc, A Technology Leader Of Neural Prosthesis And Neuromodulation System In Korea, Announced That The Company Will Introduce Their Artificial Cochlear Implant 'Sullivan' At The "Ces 2022" Which Will Be Held In Las Vegas On January 5, 2022 (Local Time), After It Was Selected In The 'Top 10 Korean Products Of Ces 2022.'Organized By The Etnews (Electronic Times Internet), "Top 10 Korean Products Of Ces 2022" Is A Project That Selects Korean Products And Services Worth Paying Attention To At This Year'S Ces. The Project Considers Originality, Marketability, Possibility Of Mass Production, And Investment Value Among Small And Medium-Sized Enterprises And Venture Companies In Korea.Based On The Vision Of Connecting The Human Nerves And The World, Todoc Has Been Providing Solutions To Curing Various Neuropathic Disorders And Conditions. Based On High-Density Electrode Technology, They Developed Sullivan, The World'S First 32-Channel Artificial Cochlear Implant System That Delivers More Frequency Band Sound Information Than Ever (Existing Artificial Cochlear Implants Support Just Up To 22 Channels). Introducing Sullivan Will Be Their Main Focus During This Exhibition.Todoc'S Articial Cochlear Implant Is Characterized By Increased Usability By Supporting User-Customized Neuromodulation And Audio Streaming Services Through An Easy-To-Wear External Ear Wearable Vagus Nerve Regulator.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!